{"count": 6, "results": [{"_id": "37305056", "pmid": 37305056, "pmcid": "PMC10248397", "title": "Jinlida granules combined with metformin improved the standard-reaching rate of blood glucose and clinical symptoms of patients with type 2 diabetes: secondary analysis of a randomized controlled trial", "journal": "Front Endocrinol (Lausanne)", "authors": ["Kang X", "Sun Y", "Duan Y", "Zhang Y", "An X", "Jin D", "Lian F", "Tong X"], "date": "2023-05-25T00:00:00Z", "doi": "10.3389/fendo.2023.1142327", "meta_date_publication": "2023", "meta_volume": "14", "meta_issue": "", "meta_pages": "1142327", "score": 50255.566, "text_hl": "From the current evidence of the trials, both Jinlida and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ reduced the level of @CHEMICAL_Blood_Glucose @CHEMICAL_MESH:D001786 @@@blood glucose@@@, and the curative effect of Jinlida add-on @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ was superior to @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ monotherapy. ", "citations": {"NLM": "Kang X, Sun Y, Duan Y, Zhang Y, An X, Jin D, Lian F, Tong X. Jinlida granules combined with metformin improved the standard-reaching rate of blood glucose and clinical symptoms of patients with type 2 diabetes: secondary analysis of a randomized controlled trial Front Endocrinol (Lausanne). 2023;14():1142327. PMID: 37305056", "BibTeX": "@article{37305056, title={Jinlida granules combined with metformin improved the standard-reaching rate of blood glucose and clinical symptoms of patients with type 2 diabetes: secondary analysis of a randomized controlled trial}, author={Kang X and Sun Y and Duan Y and Zhang Y and An X and Jin D and Lian F and Tong X}, journal={Front Endocrinol (Lausanne)}, volume={14}, pages={1142327}}"}}, {"_id": "33293761", "pmid": 33293761, "pmcid": "PMC7705076", "title": "Effect of probiotics, Bifidobacterium bifidum G9-1, on gastrointestinal symptoms in patients with type 2 diabetes mellitus: study protocol for open-label, single-arm, exploratory research trial (Big STAR study)", "journal": "J Clin Biochem Nutr", "authors": ["Hashimoto Y", "Nakajima H", "Hata S", "Miyoshi T", "Hosomi Y", "Majima S", "Nakanishi N", "Senmaru T", "Osaka T", "Okada H", "Ushigome E", "Hamaguchi M", "Asano M", "Yamazaki M", "Fukui M"], "date": "2020-11-01T00:00:00Z", "doi": "10.3164/jcbn.20-100", "meta_date_publication": "2020 Nov", "meta_volume": "67", "meta_issue": "3", "meta_pages": "223-227", "score": 50253.19, "text_hl": "In fact, according to the medical package insert, 40.5% of @SPECIES_9606 @@@patients@@@ who use @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ exhibit @DISEASE_Diarrhea @DISEASE_MESH:D003967 @@@diarrhea@@@, and >1% have @<m>DISEASE_Constipation</m> @DISEASE_MESH:D003248 @@@constipation@@@. ", "citations": {"NLM": "Hashimoto Y, Nakajima H, Hata S, Miyoshi T, Hosomi Y, Majima S, Nakanishi N, Senmaru T, Osaka T, Okada H, Ushigome E, Hamaguchi M, Asano M, Yamazaki M, Fukui M. Effect of probiotics, Bifidobacterium bifidum G9-1, on gastrointestinal symptoms in patients with type 2 diabetes mellitus: study protocol for open-label, single-arm, exploratory research trial (Big STAR study) J Clin Biochem Nutr. 2020 Nov;67(3):223-227. PMID: 33293761", "BibTeX": "@article{33293761, title={Effect of probiotics, Bifidobacterium bifidum G9-1, on gastrointestinal symptoms in patients with type 2 diabetes mellitus: study protocol for open-label, single-arm, exploratory research trial (Big STAR study)}, author={Hashimoto Y and Nakajima H and Hata S and Miyoshi T and Hosomi Y and Majima S and Nakanishi N and Senmaru T and Osaka T and Okada H and Ushigome E and Hamaguchi M and Asano M and Yamazaki M and Fukui M}, journal={J Clin Biochem Nutr}, volume={67}, number={3}, pages={223-227}}"}}, {"_id": "39350158", "pmid": 39350158, "title": "Gastrointestinal adverse events of metformin treatment in patients with type 2 diabetes mellitus: a systematic review and meta-analysis with meta-regression of observational studies.", "journal": "BMC Endocr Disord", "authors": ["Nabrdalik K", "Hendel M", "Irlik K", "Kwiendacz H", "Łoniewski I", "Bucci T", "Alam U", "Lip GYH", "Gumprecht J", "Skonieczna-Żydecka K"], "date": "2024-09-30T00:00:00Z", "doi": "10.1186/s12902-024-01727-w", "meta_date_publication": "2024 Sep 30", "meta_volume": "24", "meta_issue": "1", "meta_pages": "206", "score": 50250.375, "text_hl": "The incidence of @DISEASE_Gas_bloat_syndrome @DISEASE_MESH:C535647 @@@bloating@@@ (coefficient -4.46; p < 0.001), @DISEASE_Diarrhea @DISEASE_MESH:D003967 @@@diarrhea@@@ (coefficient -1.17; p = 0.0951) @DISEASE_Abdominal_Pain @DISEASE_MESH:D015746 @@@abdominal pain@@@ (coefficient -2.80; p = 0.001), @<m>DISEASE_Constipation</m> @DISEASE_MESH:D003248 @@@constipation@@@ (coefficient -5.78; p = 0.0014) and @DISEASE_Vomiting @DISEASE_MESH:D014839 @@@vomiting@@@ (coefficient -2.47; p < 0.001) were lower for extended release (XR) @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ than @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ immediate release (IR) formulation. ", "citations": {"NLM": "Nabrdalik K, Hendel M, Irlik K, Kwiendacz H, Łoniewski I, Bucci T, Alam U, Lip GYH, Gumprecht J, Skonieczna-Żydecka K. Gastrointestinal adverse events of metformin treatment in patients with type 2 diabetes mellitus: a systematic review and meta-analysis with meta-regression of observational studies. BMC Endocr Disord. 2024 Sep 30;24(1):206. PMID: 39350158", "BibTeX": "@article{39350158, title={Gastrointestinal adverse events of metformin treatment in patients with type 2 diabetes mellitus: a systematic review and meta-analysis with meta-regression of observational studies.}, author={Nabrdalik K and Hendel M and Irlik K and Kwiendacz H and Łoniewski I and Bucci T and Alam U and Lip GYH and Gumprecht J and Skonieczna-Żydecka K}, journal={BMC Endocr Disord}, volume={24}, number={1}, pages={206}}"}}, {"_id": "39295947", "pmid": 39295947, "title": "Efficacy and Safety of Bacillus coagulans LBSC in Drug Induced Constipation Associated With Functional Gastrointestinal Disorder: A Double-Blind, Randomized, Interventional, Parallel, Controlled Trial a Clinical Study on Bacillus coagulans LBSC for Drug Induced Constipation Associated With FGIDs.", "journal": "Glob Adv Integr Med Health", "authors": ["Rathi A", "Pagare R"], "date": "2024-09-17T00:00:00Z", "doi": "10.1177/27536130241286511", "meta_date_publication": "2024 Jan-Dec", "meta_volume": "13", "meta_issue": "", "meta_pages": "27536130241286511", "score": 50246.414, "text_hl": "Methods: A prospective, interventional, randomized, double-blind, parallel, multi-arm, controlled trial with 168 @SPECIES_9606 @@@patients@@@ experiencing drug induced @<m>DISEASE_Constipation</m> @DISEASE_MESH:D003248 @@@constipation@@@ associated with @DISEASE_Gastrointestinal_Diseases @DISEASE_MESH:D005767 @@@FGID symptoms@@@ (@DISEASE_Abnormalities_Drug_Induced @DISEASE_MESH:D000014 @@@DICAWFGID@@@) screened through Rome IV criteria were randomized into 2 arms, i.e. placebo arm (n = 28) and @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@, @CHEMICAL_Atenolol @CHEMICAL_MESH:D001262 @@@atenolol@@@, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, @CHEMICAL_Amitriptyline @CHEMICAL_MESH:D000639 @@@amitriptyline@@@, and @CHEMICAL_Calcium @CHEMICAL_MESH:D002118 @@@calcium@@@ in test arm (n = 28/arm). ", "citations": {"NLM": "Rathi A, Pagare R. Efficacy and Safety of Bacillus coagulans LBSC in Drug Induced Constipation Associated With Functional Gastrointestinal Disorder: A Double-Blind, Randomized, Interventional, Parallel, Controlled Trial a Clinical Study on Bacillus coagulans LBSC for Drug Induced Constipation Associated With FGIDs. Glob Adv Integr Med Health. 2024 Jan-Dec;13():27536130241286511. PMID: 39295947", "BibTeX": "@article{39295947, title={Efficacy and Safety of Bacillus coagulans LBSC in Drug Induced Constipation Associated With Functional Gastrointestinal Disorder: A Double-Blind, Randomized, Interventional, Parallel, Controlled Trial a Clinical Study on Bacillus coagulans LBSC for Drug Induced Constipation Associated With FGIDs.}, author={Rathi A and Pagare R}, journal={Glob Adv Integr Med Health}, volume={13}, pages={27536130241286511}}"}}, {"_id": "39455403", "pmid": 39455403, "title": "Gastrointestinal adverse effects of old and new antidiabetics: How do we deal with them in real life?", "journal": "Rev Gastroenterol Mex (Engl Ed)", "authors": ["Barrientos-Ávalos JR", "Morel-Cerda EC", "Félix-Téllez FA", "Vidrio-Huerta BE", "Aceves-Ayala AR", "Flores-Rendón ÁR", "Velarde-Ruiz Velasco JA"], "date": "2024-10-24T00:00:00Z", "doi": "10.1016/j.rgmxen.2024.10.008", "meta_date_publication": "2024 Oct 24", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50233.387, "text_hl": "Treatment for @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@ involves different medication groups, some of which can cause significant @DISEASE_Gastrointestinal_Diseases @DISEASE_MESH:D005767 @@@gastrointestinal adverse effects@@@, such as @DISEASE_Dyspepsia @DISEASE_MESH:D004415 @@@dyspepsia@@@, @DISEASE_Nausea @DISEASE_MESH:D009325 @@@nausea@@@, @DISEASE_Vomiting @DISEASE_MESH:D014839 @@@vomiting@@@, @DISEASE_Gas_bloat_syndrome @DISEASE_MESH:C535647 @@@bloating@@@, @DISEASE_Diarrhea @DISEASE_MESH:D003967 @@@diarrhea@@@, and @<m>DISEASE_Constipation</m> @DISEASE_MESH:D003248 @@@constipation@@@. The medications most frequently associated with said adverse effects are @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, @CHEMICAL_Acarbose @CHEMICAL_MESH:D020909 @@@acarbose@@@, and @GENE_GLP1R @GENE_2740 @@@GLP-1@@@ agonists. ", "citations": {"NLM": "Barrientos-Ávalos JR, Morel-Cerda EC, Félix-Téllez FA, Vidrio-Huerta BE, Aceves-Ayala AR, Flores-Rendón ÁR, Velarde-Ruiz Velasco JA. Gastrointestinal adverse effects of old and new antidiabetics: How do we deal with them in real life? Rev Gastroenterol Mex (Engl Ed). 2024 Oct 24;():. PMID: 39455403", "BibTeX": "@article{39455403, title={Gastrointestinal adverse effects of old and new antidiabetics: How do we deal with them in real life?}, author={Barrientos-Ávalos JR and Morel-Cerda EC and Félix-Téllez FA and Vidrio-Huerta BE and Aceves-Ayala AR and Flores-Rendón ÁR and Velarde-Ruiz Velasco JA}, journal={Rev Gastroenterol Mex (Engl Ed)}}"}}, {"_id": "20412573", "pmid": 20412573, "pmcid": "PMC3161395", "title": "Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes", "journal": "BMC Endocr Disord", "authors": ["Williams-Herman D", "Engel SS", "Round E", "Johnson J", "Golm GT", "Guo H", "Musser BJ", "Davies MJ", "Kaufman KD", "Goldstein BJ"], "date": "2010-04-22T00:00:00Z", "doi": "10.1186/1472-6823-10-7", "meta_date_publication": "2010 Apr 22", "meta_volume": "10", "meta_issue": "", "meta_pages": "7", "score": 50040.77, "text_hl": "Incidence rates of specific adverse events were also generally similar between the two groups, except for increased incidence rates of @DISEASE_Hypoglycemia @DISEASE_MESH:D007003 @@@hypoglycemia@@@, related to the greater use of a @CHEMICAL_Sulfonylurea_Compounds @CHEMICAL_MESH:D013453 @@@sulfonylurea@@@, and @DISEASE_Diarrhea @DISEASE_MESH:D003967 @@@diarrhea@@@, related to the greater use of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, in the non-exposed group and @<m>DISEASE_Constipation</m> @DISEASE_MESH:D003248 @@@constipation@@@ in the @CHEMICAL_Sitagliptin_Phosphate @CHEMICAL_MESH:D000068900 @@@sitagliptin@@@ group. ", "citations": {"NLM": "Williams-Herman D, Engel SS, Round E, Johnson J, Golm GT, Guo H, Musser BJ, Davies MJ, Kaufman KD, Goldstein BJ. Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes BMC Endocr Disord. 2010 Apr 22;10():7. PMID: 20412573", "BibTeX": "@article{20412573, title={Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes}, author={Williams-Herman D and Engel SS and Round E and Johnson J and Golm GT and Guo H and Musser BJ and Davies MJ and Kaufman KD and Goldstein BJ}, journal={BMC Endocr Disord}, volume={10}, pages={7}}"}}]}